ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) has launched an replace.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has introduced the primary profitable dosing in a Section...
CStone Prescription drugs (HK:2616) has launched an replace.
CStone Prescription drugs has granted unique promotion rights for AYVAKIT, a precision remedy for gastrointestinal stromal...
Share on PinterestGastric most cancers might be severe and is expounded to a number of threat components, together with dietary selections. A current...
